NeoGenomics Inc (NEO)

Industry Diagnostics & Research


This stock can be held in an Investment ISA and an Investment Account
Sell

$8.53

Buy

$9.08

arrow-down$-0.11 (-1.21%)

Prices updated at 09 May 2026, 00:27 EDT
| Prices minimum 15 mins delay
|
Prices in USD

NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Ms. Lynn A. Tetrault, J.D.
CEO
Mr. Anthony P. Zook
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
2,500
Head office
9490 NeoGenomics Way
Fort Myers
United States
33912
mobile
+1 239 768-0600
letter
bill.bonello@neogenomics.com

Key personnel

Salary
Mr. Abhishek Jain
Chief Financial Officer
-
Ms. Lynn A. Tetrault, J.D.
Non-Executive Chairman of the Board
0.13m
Mr. Anthony P. Zook
Director and Chief Executive Officer
0.60m
Mr. Michael A. Kelly
Independent Director
0.08m
Mr. Gregory D. Aunan
Chief Accounting Officer
-
Mr. Stephen M. Kanovsky
Independent Director
0.06m
Mr. John Patrick Kenny
Director
-
Mr. David B. Perez
Independent Director
0.08m
Ms. Alicia C. Olivo
Executive Vice President, Business Development and General Counsel
0.52m
Mr. Warren C. Stone
President and Chief Operating Officer
0.63m
Dr. Neil Gunn
Independent Director
0.07m
Ms. Felicia Williams
Independent Director
0.07m
Dr. Marjorie C. Green
Independent Director
0.03m

Top 5 shareholders

No. of shares
BlackRock Inc19,461,349
Vanguard Group Inc13,828,355
BlackRock Fund Advisors13,793,602
First Trust Advisors L.P.10,098,692
First Light Asset Management, LLC10,035,063

Director dealings

Action
07 Dec 2025-
01 Dec 2025-
25 Nov 2025-
25 Nov 2025-
25 Nov 2025-
16 Oct 2025-
01 Sep 2025-
06 Aug 2025-
06 Aug 2025-
01 Aug 2025-
19 Jun 2025-
19 Jun 2025-
01 Jun 2025-
01 Jun 2025-
01 Jun 2025-
01 Jun 2025-
01 Jun 2025-
01 Jun 2025-
01 Jun 2025-
01 Jun 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.